PYXSPyxis Oncology, Inc.
- Market cap
- $200.69M
- as of 2026-10-23
- Latest close
- $1.68
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-17
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| GordonMD Global Investments LP | Oct 1 | Oct 94/A | P · derivative | 7,172,000 | $3.50 | Purchase +$25,102,000 | 7,172,000 | No | Form 4/A |
| Civik ThomasCEO & Chairman of the Board | Sep 4 | Sep 8 | A · derivative | 2,503,050 | $3.89 | $9,736,865 | 2,503,050 | No | Form 4 |
| Dupont Jakob | Aug 20 | Aug 20 | A · derivative | 46,000 | $3.12 | $143,520 | 46,000 | No | Form 4 |
| Civik ThomasInterim CEO | Aug 12 | Aug 14 | A · derivative | 250,956 | $1.49 | $373,924 | 941,087 | No | Form 4 |
| Dupont Jakob | Jun 30 | Jul 2 | M | 35,000 | $1.60 | $56,000 | 73,741 | Yes | Form 4 |
| Dupont Jakob | Jun 30 | Jul 2 | S | 35,000 | $3.06 | Sale −$107,100 | 38,741 | Yes | Form 4 |
| Dupont Jakob | Jun 30 | Jul 2 | M · derivative | 35,000 | $1.60 | $56,000 | 357,461 | Yes | Form 4 |
| Palani Santhosh | Mar 24 | Mar 25 | A · derivative | 45,867 | $1.36 | $62,379 | 45,867 | No | Form 4 |
| Humphrey Rachel | Mar 24 | Mar 25 | A · derivative | 45,867 | $1.36 | $62,379 | 45,867 | No | Form 4 |
| Cline Darren S | Mar 24 | Mar 25 | A · derivative | 45,867 | $1.36 | $62,379 | 45,867 | No | Form 4 |
| Lewis-Hall Freda C | Mar 24 | Mar 25 | A · derivative | 45,867 | $1.36 | $62,379 | 45,867 | No | Form 4 |
| Metzger Michael A | Mar 24 | Mar 25 | A · derivative | 45,867 | $1.36 | $62,379 | 45,867 | No | Form 4 |
| Flavin John L | Mar 24 | Mar 25 | A · derivative | 45,867 | $1.36 | $62,379 | 45,867 | No | Form 4 |
| Wadhane JitendraPrin Fin & Acct Officer | Mar 24 | Mar 25 | A | 109,461 | $0.00 | $0 | 512,882 | No | Form 4 |
| Wadhane JitendraPrin Fin & Acct Officer | Mar 24 | Mar 25 | A · derivative | 262,635 | $1.36 | $357,184 | 262,635 | No | Form 4 |
| Dupont Jakob | Mar 24 | Mar 25 | A · derivative | 45,867 | $1.36 | $62,379 | 45,867 | No | Form 4 |
| Humphrey Rachel | Apr 21, 2025 | Mar 25 | S | 13,896 | $1.03 | Sale −$14,313 | 81,309 | Yes | Form 4 |
| Humphrey Rachel | Apr 17, 2025 | Mar 25 | S | 200 | $0.97 | Sale −$194 | 95,205 | Yes | Form 4 |
| Humphrey Rachel | Apr 14, 2025 | Mar 25 | S | 1,400 | $0.97 | Sale −$1,358 | 95,405 | Yes | Form 4 |
| Civik ThomasInterim CEO | Feb 3 | Feb 5 | A · derivative | 690,131 | $1.49 | $1,028,295 | 690,131 | No | Form 4 |
| Flavin John L | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 36,979 | $0.98 | $36,239 | 36,979 | No | Form 4 |
| Connealy Pamela AnnCFO & COO | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 414,163 | $0.98 | $405,880 | 414,163 | No | Form 4 |
| Civik Thomas | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 36,979 | $0.98 | $36,239 | 36,979 | No | Form 4 |
| Palani Santhosh | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 36,979 | $0.98 | $36,239 | 36,979 | No | Form 4 |
| Dupont Jakob | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 36,979 | $0.98 | $36,239 | 36,979 | No | Form 4 |
| Cline Darren S | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 36,979 | $0.98 | $36,239 | 36,979 | No | Form 4 |
| Lewis-Hall Freda C | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 36,979 | $0.98 | $36,239 | 36,979 | No | Form 4 |
| Humphrey Rachel | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 36,979 | $0.98 | $36,239 | 36,979 | No | Form 4 |
| Wadhane JitendraSVP, Chief Accounting Officer | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 263,782 | $0.98 | $258,506 | 263,782 | No | Form 4 |
| Metzger Michael A | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 36,979 | $0.98 | $36,239 | 36,979 | No | Form 4 |
| Sullivan LaraPresident ,CEO & CMO | Mar 31, 2025 | Apr 2, 2025 | A · derivative | 918,308 | $0.98 | $899,942 | 918,308 | No | Form 4 |
| Wadhane JitendraSVP, Chief Accounting Officer | Dec 23, 2024 | Dec 23, 2024 | A · derivative | 150,000 | $1.67 | $250,500 | 150,000 | No | Form 4 |
| Connealy Pamela AnnCFO & COO | Dec 23, 2024 | Dec 23, 2024 | A · derivative | 310,000 | $1.67 | $517,700 | 310,000 | No | Form 4 |
| Sullivan LaraChief Executive Officer | Dec 23, 2024 | Dec 23, 2024 | A · derivative | 1,135,000 | $1.67 | $1,895,450 | 1,135,000 | No | Form 4 |
| Connealy Pamela AnnCFO & COO | Nov 26, 2024 | Nov 27, 2024 | P | 5,450 | $2.00 | Purchase +$10,900 | 1,115,743 | No | Form 4 |
| Connealy Pamela AnnCFO & COO | Nov 26, 2024 | Nov 27, 2024 | P | 83,400 | $1.96 | Purchase +$163,464 | 1,199,143 | No | Form 4 |
| Metzger Michael A | Jun 10, 2024 | Jun 10, 2024 | A · derivative | 70,683 | $3.97 | $280,612 | 70,683 | No | Form 4 |
| Palani Santhosh | Jun 7, 2024 | Jun 7, 2024 | A | 6,000 | $0.00 | $0 | 6,000 | No | Form 4 |
| Wadhane JitendraSVP, Chief Accounting Officer | Mar 26, 2024 | Mar 28, 2024 | A | 131,484 | $0.00 | $0 | 398,421 | No | Form 4 |
| Civik Thomas | Mar 26, 2024 | Mar 28, 2024 | A · derivative | 44,024 | $3.83 | $168,612 | 44,024 | No | Form 4 |
| Humphrey Rachel | Mar 26, 2024 | Mar 28, 2024 | A | 38,741 | $0.00 | $0 | 96,805 | No | Form 4 |
| Dupont Jakob | Mar 26, 2024 | Mar 28, 2024 | A | 38,741 | $0.00 | $0 | 38,741 | No | Form 4 |
| Lewis-Hall Freda C | Mar 26, 2024 | Mar 28, 2024 | A | 35,219 | $0.00 | $0 | 241,405 | No | Form 4 |
| Flavin John L | Mar 26, 2024 | Mar 28, 2024 | A | 35,219 | $0.00 | $0 | 413,015 | No | Form 4 |
| Cline Darren S | Mar 26, 2024 | Mar 28, 2024 | A | 35,219 | $0.00 | $0 | 251,405 | No | Form 4 |
| Sullivan LaraChief Executive Officer | Mar 26, 2024 | Mar 28, 2024 | A · derivative | 1,071,242 | $3.83 | $4,102,857 | 1,071,242 | No | Form 4 |
| Connealy Pamela AnnCFO & COO | Mar 26, 2024 | Mar 28, 2024 | A | 328,710 | $0.00 | $0 | 1,110,293 | No | Form 4 |
| Palani Santhosh | Mar 12, 2024 | Mar 13, 2024 | A · derivative | 69,760 | $5.70 | $397,632 | 69,760 | No | Form 4 |
| Kobayashi KenChief Medical Officer | Dec 29, 2023 | Dec 29, 2023 | A · derivative | 443,514 | $1.80 | $798,325 | 443,514 | No | Form 4 |
| Kobayashi KenChief Medical Officer | Dec 29, 2023 | Dec 29, 2023 | A · derivative | 110,878 | $1.80 | $199,580 | 110,878 | No | Form 4 |
| Connealy Pamela AnnCFO and COO | Nov 29, 2023 | Nov 30, 2023 | F | 36,949 | $1.40 | $51,729 | 781,583 | No | Form 4 |
| Wadhane JitendraChief Accounting Officer | Nov 15, 2023 | Nov 17, 2023 | A | 40,000 | $0.00 | $0 | 266,937 | No | Form 4 |